{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:38:50Z","timestamp":1748468330960},"reference-count":38,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>An increasing number of women who become pregnant have pre-existing hypertension. For this group of women, a proportion will develop pre-eclampsia or severe hypertension which can impact on maternal and fetal well-being. Women with raised blood pressure should be offered reliable contraception when they do not wish to conceive and pre-conception counselling to address pregnancy-related concerns and advice on preparation for pregnancy and the use of medicines. For women with a history of hypertension, the smallest number of safe medicines at the lowest effective doses should be used while preparing for and during pregnancy. This article forms part of the series of prescribing for pregnancy and discusses the impact of hypertension on pregnancy, the impact of pregnancy on hypertension and options for treatment.<\/jats:p>","DOI":"10.1136\/dtb.2021.000051","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T18:22:03Z","timestamp":1643739723000},"page":"60-63","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Prescribing for pregnancy: chronic hypertension"],"prefix":"10.1136","volume":"60","author":[{"given":"Anja","family":"Johansen-Bibby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"2023093009551222000_60.4.60.1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMcp0804872","article-title":"Chronic hypertension in pregnancy","volume":"365","author":"Seely","year":"2011","journal-title":"N Engl J Med Overseas Ed"},{"key":"2023093009551222000_60.4.60.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2023093009551222000_60.4.60.3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"2023093009551222000_60.4.60.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2301"},{"key":"2023093009551222000_60.4.60.5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09972"},{"key":"2023093009551222000_60.4.60.6","unstructured":"Knight M , Nair M , Tuffnell . on behalf of MBRRACE-UK. Saving Lives, Improving Mothers\u2019 Care - Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14. Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2016."},{"key":"2023093009551222000_60.4.60.7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.107565"},{"key":"2023093009551222000_60.4.60.8","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2023093009551222000_60.4.60.9","unstructured":"National Institute for Health and Clinical Excellence . Hypertension in pregnancy: diagnosis and management (NG 133) [online], 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng133 [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.10","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2018.000062"},{"key":"2023093009551222000_60.4.60.11","unstructured":"National Institute for Health and Care Excellence . Clinical Knowledge Summary - antenatal care - uncomplicated pregnancy [online], 2021. Available: https:\/\/cks.nice.org.uk\/topics\/antenatal-care-uncomplicated-pregnancy\/management\/antenatal-care-uncomplicated-pregnancy\/#nutritional-supplements [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.12","unstructured":"National Institute for Health and Clinical Excellence . Hypertension in adults: diagnosis and management (NG 136) [online], 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng136 [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.13","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH guidelines for the management of arterial hypertension","volume":"2018","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2023093009551222000_60.4.60.14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002870"},{"key":"2023093009551222000_60.4.60.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182874"},{"key":"2023093009551222000_60.4.60.16","doi-asserted-by":"crossref","unstructured":"Duley L , Meher S , Hunter KE . Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2019;2019:10.1002\/14651858.CD004659.pub3.doi:10.1002\/14651858.CD004659.pub3","DOI":"10.1002\/14651858.CD004659.pub3"},{"key":"2023093009551222000_60.4.60.17"},{"key":"2023093009551222000_60.4.60.18","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: Green-top guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"key":"2023093009551222000_60.4.60.19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0000000000002800","article-title":"Timing of delivery in women with chronic hypertension","volume":"132","author":"Ram","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2023093009551222000_60.4.60.20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2019.12.001","article-title":"Home blood pressure monitoring in the antenatal and postpartum period: a systematic review meta-analysis","volume":"19","author":"Kalafat","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"2023093009551222000_60.4.60.21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005526"},{"key":"2023093009551222000_60.4.60.22","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07862"},{"key":"2023093009551222000_60.4.60.23","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2018.9.000008"},{"key":"2023093009551222000_60.4.60.24","unstructured":"Joint Formulary Committee . British National Formulary [online], 2021. Available: https:\/\/bnf.nice.org.uk\/ [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.25","unstructured":"UKTIS . Use of labetalol in pregnancy [online], 2020. Available: https:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-LABETALOL-IN-PREGNANCY\/ [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.26","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0187-7"},{"key":"2023093009551222000_60.4.60.27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/uog.7611","article-title":"Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders","volume":"35","author":"Khalil","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023093009551222000_60.4.60.28","unstructured":"Kings College London . Action on Pre-Eclampsia, NIHR. High blood pressure in pregnancy decision aid [online], 2019. Available: https:\/\/action-on-pre-eclampsia.org.uk\/wp-content\/uploads\/2019\/11\/High-blood-pressure-in-pregnancy-blood-pressure-PDA-WEB.pdf [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055202"},{"key":"2023093009551222000_60.4.60.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.03151.x"},{"key":"2023093009551222000_60.4.60.31","doi-asserted-by":"crossref","unstructured":"Duley L , Matar HE , Almerie MQ . Alternative magnesium sulphate regimens for women with pre\u2010eclampsia and eclampsia. Cochrane Database Syst Revs 2010;8:10.1002\/14651858.CD007388.pub2.","DOI":"10.1002\/14651858.CD000025.pub2"},{"key":"2023093009551222000_60.4.60.32","unstructured":"National Institute for Health and Care Excellence . Preterm labour and birth (NG25) [online], 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng25\/ [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.33","doi-asserted-by":"crossref","unstructured":"Gallos ID , Papadopoulou A , Man R . Uterotonic agents for preventing postpartum haemorrhage: a network meta\u2010analysis. Cochrane Database of Systematic Reviews 2018;12:10.1002\/14651858.CD011689.","DOI":"10.1002\/14651858.CD011689.pub3"},{"key":"2023093009551222000_60.4.60.34","doi-asserted-by":"crossref","unstructured":"Mavrides E , Papadopoulou A , Man R . Prevention and management of postpartum haemorrhage. BJOG 2016;124:e106.","DOI":"10.1111\/1471-0528.14178"},{"key":"2023093009551222000_60.4.60.35","unstructured":"National Institute for Health and Care Excellence . Clinical Knowledge Summary \u2013 hypertension in pregnancy [online], 2020. Available: https:\/\/cks.nice.org.uk\/topics\/hypertension-in-pregnancy\/management\/postpartum-follow-up\/ [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.36","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.035444"},{"key":"2023093009551222000_60.4.60.37","unstructured":"National Library of Medicine . Drugs and lactation database (LactMed): atenolol [online], 2021. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501142 [Accessed 12 Jan 2022]."},{"key":"2023093009551222000_60.4.60.38","unstructured":"Faculty of Sexual and Reproductive Healthcare . UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) summary table [online], 2019. Available: https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/ukmec-2016-summary-sheets [Accessed 12 Jan 2022]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2021.000051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:21:36Z","timestamp":1700158896000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2021.000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,31]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/dtb.2021.000051"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2021.000051","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}